Zustand: As New. Unread book in perfect condition.
Zustand: New.
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
EUR 67,76
Anzahl: 3 verfügbar
In den WarenkorbZustand: New. pp. 392.
Zustand: New. pp. 392.
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
EUR 67,06
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New.
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
EUR 66,65
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: As New. Unread book in perfect condition.
Anbieter: THE SAINT BOOKSTORE, Southport, Vereinigtes Königreich
EUR 67,08
Anzahl: 1 verfügbar
In den WarenkorbPaperback / softback. Zustand: New. New copy - Usually dispatched within 4 working days.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 76,52
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Anbieter: Biblios, Frankfurt am main, HESSE, Deutschland
Zustand: New. pp. 392.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 100,59
Anzahl: 2 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. 392 pages. 10.00x7.01x0.98 inches. In Stock.
Taschenbuch. Zustand: Neu. A Guide to Outcome Modeling In Radiotherapy and Oncology | Listening to the Data | Issam El Naqa | Taschenbuch | Einband - flex.(Paperback) | Englisch | 2020 | CRC Press | EAN 9780367572082 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu.
PAP. Zustand: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Anbieter: PBShop.store UK, Fairford, GLOS, Vereinigtes Königreich
EUR 77,54
Anzahl: Mehr als 20 verfügbar
In den WarenkorbPAP. Zustand: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Anbieter: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Deutschland
Taschenbuch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This book explores outcome modeling in cancer from a data-centric perspective to enable a better understanding of complex treatment response, to guide the design of advanced clinical trials, and to aid personalized patient care and improve their quality of life. It contains coverage of the relevant data sources available for model construction (panomics), ranging from clinical or preclinical resources to basic patient and treatment characteristics, medical imaging (radiomics), and molecular biological markers such as those involved in genomics, proteomics and metabolomics. It also includes discussions on the varying methodologies for predictive model building with analytical and data-driven approaches.This book is primarily intended to act as a tutorial for newcomers to the field of outcome modeling, as it includes in-depth how-to recipes on modeling artistry while providing sufficient instruction on how such models can approximate the physical and biological realities of clinical treatment. The book will also be of value to seasoned practitioners as a reference on the varying aspects of outcome modeling and their current applications.Features:Covers top-down approaches applying statistical, machine learning, and big data analytics and bottom-up approaches using first principles and multi-scale techniques, including numerical simulations based on Monte Carlo and automata techniquesProvides an overview of the available software tools and resources for outcome model development and evaluation, and includes hands-on detailed examples throughout Presents a diverse selection of the common applications of outcome modeling in a wide variety of areas: treatment planning in radiotherapy, chemotherapy and immunotherapy, utility-based and biomarker applications, particle therapy modeling, oncological surgery, and the design of adaptive and SMART clinical trials 392 pp. Englisch.
Anbieter: moluna, Greven, Deutschland
EUR 56,83
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Issam El Naqa is an Associate Professor of Radiation Oncology at the University of Michigan at Ann Arbor, USA.This book explores outcome modeling in cancer from a data-centric perspective to enable a better understanding of complex treatme.
Taschenbuch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - This book explores outcome modeling in cancer from a data-centric perspective to enable a better understanding of complex treatment response, to guide the design of advanced clinical trials, and to aid personalized patient care and improve their quality of life. It contains coverage of the relevant data sources available for model construction (panomics), ranging from clinical or preclinical resources to basic patient and treatment characteristics, medical imaging (radiomics), and molecular biological markers such as those involved in genomics, proteomics and metabolomics. It also includes discussions on the varying methodologies for predictive model building with analytical and data-driven approaches.This book is primarily intended to act as a tutorial for newcomers to the field of outcome modeling, as it includes in-depth how-to recipes on modeling artistry while providing sufficient instruction on how such models can approximate the physical and biological realities of clinical treatment. The book will also be of value to seasoned practitioners as a reference on the varying aspects of outcome modeling and their current applications.Features:Covers top-down approaches applying statistical, machine learning, and big data analytics and bottom-up approaches using first principles and multi-scale techniques, including numerical simulations based on Monte Carlo and automata techniquesProvides an overview of the available software tools and resources for outcome model development and evaluation, and includes hands-on detailed examples throughout Presents a diverse selection of the common applications of outcome modeling in a wide variety of areas: treatment planning in radiotherapy, chemotherapy and immunotherapy, utility-based and biomarker applications, particle therapy modeling, oncological surgery, and the design of adaptive and SMART clinical trials.